. "Kopeck\u00FD, Jan" . "RIV/67985823:_____/12:00377920!RIV13-MZ0-67985823" . "n-3 PUFA; marine phospholipids; obesity; insulin resistance"@en . . "Verhoeckx, K.C.M." . "Tvrzick\u00E1, E." . "Metabolic Effects of n-3 PUFA as Phospholipids Are Superior to Triglycerides in Mice Fed a High-Fat Diet: Possible Role of Endocannabinoids" . . "Balvers, M.G.J." . . . . "I, P(GAP301/10/1420), P(NS10528), Z(AV0Z50110509)" . . "Metabolic Effects of n-3 PUFA as Phospholipids Are Superior to Triglycerides in Mice Fed a High-Fat Diet: Possible Role of Endocannabinoids"@en . . "10.1371/journal.pone.0038834" . . "US - Spojen\u00E9 st\u00E1ty americk\u00E9" . "Jelen\u00EDk, Tom\u00E1\u0161" . "Med\u0159\u00EDkov\u00E1, Da\u0161a" . "7" . "Haraldsson, G. G." . "Metabolic Effects of n-3 PUFA as Phospholipids Are Superior to Triglycerides in Mice Fed a High-Fat Diet: Possible Role of Endocannabinoids" . "6" . "Kuda, Ond\u0159ej" . "Kristinsson, B." . "Macek J\u00EDlkov\u00E1, Zuzana" . "Sta\u0148kov\u00E1, B." . . "1932-6203" . "Sj\u00F6vall, P." . "17"^^ . "6"^^ . "Metabolic Effects of n-3 PUFA as Phospholipids Are Superior to Triglycerides in Mice Fed a High-Fat Diet: Possible Role of Endocannabinoids"@en . . "Rossmeisl, Martin" . . . . "000305337600048" . . . "Svensen, H." . . "Bryhn, M." . "RIV/67985823:_____/12:00377920" . . "Magnusson, Y." . "149599" . "n-3 polyunsaturated fatty acids, namely docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), reduce the risk of cardiovascular disease and can ameliorate many of obesity- associated disorders. Compared with triglycerides, dietary DHA/EPA administered as phospholipids are superior in preserving a healthy metabolic profile under obesogenic conditions, possibly reflecting better bioavalability and improved modulation of the endocannabinoid system activity in WAT of mice" . "13"^^ . . . . . . "Stoknes, I." . . . "n-3 polyunsaturated fatty acids, namely docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), reduce the risk of cardiovascular disease and can ameliorate many of obesity- associated disorders. Compared with triglycerides, dietary DHA/EPA administered as phospholipids are superior in preserving a healthy metabolic profile under obesogenic conditions, possibly reflecting better bioavalability and improved modulation of the endocannabinoid system activity in WAT of mice"@en . "[01D3D3BA1E10]" . . "PLoS ONE" .